መነሻ › ሉፑስ ኔፍራይቲስ › North Carolina
በNorth Carolina ለሉፑስ ኔፍራይቲስ የሚደረጉ ክሊኒካዊ ጥናቶች
ለሉፑስ ኔፍራይቲስ የሚደረጉ 11 ጥናቶች በNorth Carolina ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በNorth Carolina ውስጥ ያሉ ከተሞች
Official study text (English)
The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
- University of North Carolina at Chapel Hill, Chapel Hill
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ8 እስከ 20 · ሁሉም ጾታዎች · የተሻሻለው በ14 ሴፕቴ 2026 · NCT05538208A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
- Cross Creek Medical Clinic, Fayetteville
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ12 እስከ 70 · ሁሉም ጾታዎች · የተሻሻለው በ14 ሴፕቴ 2026 · NCT07570862A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
- Research Site, Chapel Hill
- Research Site, Charlotte
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ ከ18 እስከ 70 · ሁሉም ጾታዎች · የተሻሻለው በ10 ሴፕቴ 2026 · NCT06897930A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Atrium Health Rheumatology-Southpark, Charlotte
- Duke University Medical Center, Durham
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ18 እስከ 74 · ሁሉም ጾታዎች · የተሻሻለው በ10 ሴፕቴ 2026 · NCT07085104A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
- University of North Carolina TraCS Institute - CTRC, Chapel Hill
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ18 እስከ 70 · ሁሉም ጾታዎች · የተሻሻለው በ28 ኦገስ 2026 · NCT06925542RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- UNC Chapel Hill, Chapel Hill
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ ከ18 እስከ 65 · ሁሉም ጾታዎች · የተሻሻለው በ26 ኦገስ 2026 · NCT06121297PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
- Arthritis and Osteoporosis Consultants of the Carolinas, Charlotte
- Joint and Muscle Research Institute, Charlotte
ተሳታዮችን በመፈለግ ላይደረጃ 4
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ3 ኦገስ 2026 · NCT07611214A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
- Duke University, Durham
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ14 ጁላይ 2026 · NCT07115745Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN
- GSK Investigational Site, Charlotte
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ጁላይ 2026 · NCT06527872A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Duke University Health System, Durham
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ12 እስከ 70 · ሁሉም ጾታዎች · የተሻሻለው በ22 ሜይ 2026 · NCT06308978Lupus Landmark Study: A Prospective Registry and Biorepository
- UNC Chapel Hill, Chapel Hill
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ ከ18 እስከ 110 · ሁሉም ጾታዎች · የተሻሻለው በ15 ኤፕሪ 2026 · NCT05934149ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።